UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Flavanols, the Kuna, cocoa consumption, and nitric oxide

Journal of the American Society of Hypertension, 2009-03, Vol.3 (2), p.105-112

2009

Volltextzugriff (PDF)

Evaluation of a direct prorenin assay making use of a monoclonal antibody directed against residues 32-39 of the prosegment

Journal of hypertension, 2011-11, Vol.29 (11), p.2138-2146

2011

Volltextzugriff (PDF)

Renin inhibition with aliskiren : where are we now, and where are we going?

Journal of hypertension, 2006-02, Vol.24 (2), p.243-256

2006

Volltextzugriff (PDF)

Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans

Journal of hypertension, 2003-12, Vol.21 (12), p.2281-2286

2003

Volltextzugriff (PDF)

Direct renin inhibition and the kidney

Nature reviews. Nephrology, 2010-01, Vol.6 (1), p.49-55

Hollenberg, Norman K

2010

Volltextzugriff (PDF)

Considerations for management of fluid dynamic issues associated with thiazolidinediones

The American journal of medicine, 2003-12, Vol.115 (8), p.111-115

Hollenberg, Norman K

2003

Volltextzugriff (PDF)

Is there room for dual blockade of the renin–angiotensin–aldosterone system?

Journal of hypertension, 2012-04, Vol.30 (4), p.671-672

Hollenberg, Norman K

2012

Volltextzugriff (PDF)

Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus

Journal of hypertension, 2007-09, Vol.25 (9), p.1921-1926

2007

Volltextzugriff (PDF)

Renin Inhibition: What Are the Clinical Perspectives?

Seminars in nephrology, 2007-09, Vol.27 (5), p.511-518

Hollenberg, Norman K., MD, PhD

2007

Volltextzugriff (PDF)

Aging and vascular responses to flavanol-rich cocoa

Journal of hypertension, 2006-08, Vol.24 (8), p.1575-1580

2006

Volltextzugriff (PDF)

Something New to Offer: Renal Denervation

Current hypertension reports, 2011-12, Vol.13 (6), p.400-400

Hollenberg, Norman K.

2011

Volltextzugriff (PDF)

Improving Genetic Testing for Gitelman’s Syndrome

Current hypertension reports, 2011-10, Vol.13 (5), p.328-329

Hollenberg, Norman K.

2011

Volltextzugriff (PDF)

Influencing the natural history of hypertension: is it the blood pressure achieved, the drug, or the drug dose?

Journal of hypertension, 2008-08, Vol.26 (8), p.1527-1532

Hollenberg, Norman K

2008

Volltextzugriff (PDF)

Aldosterone Synthase Inhibition: A Promising Beginning

Current hypertension reports, 2011-04, Vol.13 (2), p.99-102

Hollenberg, Norman K.

2011

Volltextzugriff (PDF)

Body Mass and Risk

Current hypertension reports, 2011-08, Vol.13 (4), p.268-268

Hollenberg, Norman K.

2011

Volltextzugriff (PDF)

Diabetic Retinopathy and Blockade of the Renin-Angiotensin System: So What is New?

Current hypertension reports, 2011-06, Vol.13 (3), p.176-176

Hollenberg, Norman K.

2011

Volltextzugriff (PDF)

Obesity and the Kidney: Obesity in Asia

Current hypertension reports, 2011-02, Vol.13 (1), p.11-13

Hollenberg, Norman K.

2011

Volltextzugriff (PDF)

Renal plasma flow: glomerular filtration rate relationships in man during direct renin inhibition with aliskiren

Journal of the American Society of Hypertension, 2009-09, Vol.3 (5), p.315-320

2009

Volltextzugriff (PDF)

Maximum renal responses to renin inhibition in healthy study participants: VTP-27999 versus aliskiren

Journal of hypertension, 2016-05, Vol.34 (5), p.935-941

2016

Volltextzugriff (PDF)

Renal responses to three types of renin–angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients?

Journal of hypertension, 2011-12, Vol.29 (12), p.2454-2461

2011

Volltextzugriff (PDF)

The Metabolic Syndrome: How Do We Get There?

Current hypertension reports, 2010-08, Vol.12 (4), p.210-211

Hollenberg, Norman K.

2010

Volltextzugriff (PDF)

Prorenin: Where Does It Stand?

Current hypertension reports, 2010-10, Vol.12 (5), p.323-324

Hollenberg, Norman K.

2010

Volltextzugriff (PDF)

Mortality in type 2 diabetes mellitus

Journal of hypertension, 2007-12, Vol.25 (12), p.2381-2382

Hollenberg, Norman K

2007

Volltextzugriff (PDF)

Angiotensin receptor blockers: dose does matter

Journal of hypertension, 2008-03, Vol.26 (3), p.608-608

Hollenberg, Norman K

2008

Volltextzugriff (PDF)

Renin System Blockade, the Eye, and the Kidney in Type 1 Diabetes Mellitus

Current hypertension reports, 2010-06, Vol.12 (3), p.152-153

Hollenberg, Norman K.

2010

Volltextzugriff (PDF)

1 – 25 von 273

Menü

Weitere Dienste

Einstellungen

Flavanols, the Kuna, cocoa consumption, and nitric oxide

Evaluation of a direct prorenin assay making use of a monoclonal antibody directed against residues 32-39 of the prosegment

Renin inhibition with aliskiren : where are we now, and where are we going?

Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans

Direct renin inhibition and the kidney

Considerations for management of fluid dynamic issues associated with thiazolidinediones

Is there room for dual blockade of the renin–angiotensin–aldosterone system?

Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus

Renin Inhibition: What Are the Clinical Perspectives?

Aging and vascular responses to flavanol-rich cocoa

Something New to Offer: Renal Denervation

Improving Genetic Testing for Gitelman’s Syndrome

Influencing the natural history of hypertension: is it the blood pressure achieved, the drug, or the drug dose?

Aldosterone Synthase Inhibition: A Promising Beginning

Body Mass and Risk

Diabetic Retinopathy and Blockade of the Renin-Angiotensin System: So What is New?

Obesity and the Kidney: Obesity in Asia

Renal plasma flow: glomerular filtration rate relationships in man during direct renin inhibition with aliskiren

Maximum renal responses to renin inhibition in healthy study participants: VTP-27999 versus aliskiren

Renal responses to three types of renin–angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients?

The Metabolic Syndrome: How Do We Get There?

Prorenin: Where Does It Stand?

Mortality in type 2 diabetes mellitus

Angiotensin receptor blockers: dose does matter

Renin System Blockade, the Eye, and the Kidney in Type 1 Diabetes Mellitus

Aktive Filter

Suchergebnisse filtern